Invention Grant
- Patent Title: Compositions and methods for immunooncology
-
Application No.: US16498361Application Date: 2018-03-21
-
Publication No.: US11851659B2Publication Date: 2023-12-26
- Inventor: Jennifer Brogdon , Ming-Wei Chen , Hyungwook Lim , Yi Yang , Morag Stewart , Sarah Hesse
- Applicant: Novartis AG , Intellia Therapeutics, Inc.
- Applicant Address: CH MA Basel
- Assignee: Novartis AG,Intellia Therapeutics, Inc.
- Current Assignee: Novartis AG,Intellia Therapeutics, Inc.
- Current Assignee Address: CH Basel; US MA Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- International Application: PCT/US2018/023631 2018.03.21
- International Announcement: WO2018/175636A 2018.09.27
- Date entered country: 2019-09-26
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/86 ; C12N15/113 ; A61K35/17 ; C07K14/705
Abstract:
The present disclosure is directed to genome editing systems, reagents and methods for immunooncology.
Public/Granted literature
- US20210071182A1 COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY Public/Granted day:2021-03-11
Information query
